- 27,584$5.6B
1
- 70,000$14.1B
2
- 32,065$8.5B
3
- 46,500$193B
4
- 75,000$18.7B
5
- 36,000$9.8B
6
Baxter
Manufacturing · Illinois, United States · 60,000 Employees
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs anddrug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield.Read More
View Company Info for Free
Who is Baxter
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Top Competitors of Baxter
Baxter Org Chart
Baxter Email Formats
Baxter uses at least 5 email formats with first_last (ex. John_Smith@baxter.com) being used 66.3% of the time
Baxter Email Formats | Percentage | |
---|---|---|
first_last | John_Smith@baxter.com | 66.3% |
first.last | John.Smith@baxter.com | 6.9% |
first initials + last | JSmith@baxter.com | 5.9% |
first + last | JohnSmith@baxter.com | |
first | John@baxter.com |
Get Verified Emails
Baxter Company Metrics
Jul 18, 2022
TRUMPF
Jul 18, 2022
Werner Trumpf
Jul 18, 2022
QUINTON CARDIOLOGY
Jul 18, 2022
Burdick
Nov 17, 2021
Connecta Soft, SA de CV
Nov 01, 2017
EHT Werkzeugmaschinen
See More Acquisitions & Subsidiaries
Baxter Tech Stack
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Baxter News & Media
The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in Egypt
DEERFIELD, Ill. & NEW YORK--(BUSINESS WIRE)--The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve access to safe drinking water and sanitation in five water-challenged regions in Egypt. Supported by a $2.5 million grant from the Foundation, this three-year initiative aims to implement climate-smart water, sanitation and hygiene (WASH) programming for thousands of people in Upper Egypt’s governora12 High Dividend Stocks Picked By Billionaire Ray Dalio
In this article, we discuss 12 high-dividend stocks picked by billionaire Ray Dalio. You can skip our detailed analysis of Bridgewater Associates’ performance and recent developments, and go directly to read 5 High Dividend Stocks Picked By Billionaire Ray Dalio. Bridgewater Associates is a renowned investment management firm founded by Ray Dalio in 1975. It […]Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 2, 2024, to shareholders of record as of December 1, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolioBaxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter’s Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal dialysis (PD) system, is associated with a 77% reduction in risk of PD technique failure. Technique failure can be due to several factors and results in PD patients being switched to in-center dialysis. Additional key data
Frequently Asked Questions regarding Baxter
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV n... Read More